Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
co decrease » _ decrease (Expand Search), nn decrease (Expand Search), c decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
co decrease » _ decrease (Expand Search), nn decrease (Expand Search), c decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1481
-
1482
-
1483
-
1484
-
1485
The Laboratory Animal Flow Diagram.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1486
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1487
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1488
The structures of T3 and Kylo-0603.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1489
Synthesis process of Kylo-0603.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1490
ESI-HRMS spectra for Kylo-0603.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1491
-
1492
-
1493
-
1494
-
1495
-
1496
-
1497
-
1498
Data Sheet 1_Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer.docx
Published 2025“…EA treatment (25 mg/kg) markedly inhibited tumour growth in vivo in a xenograft model; both tumour weight and tumour volume decreased by more than 60% without significantly affecting the body weight of tumour-bearing mice.…”
-
1499
-
1500